Walgreens, Rite Aid To Cut $2B Off Deal Value In Effort To Win Regulatory Approval

Walgreens

After struggling to gain regulatory approval for their proposed merger, Walgreens Boots Alliance and Rite Aid just agreed to reduce the merger price by at least $2B.

On Monday the two firms agreed to sell off 200 more stores, lowering Rite Aid’s value to between $6.8B and $7.4B, the Wall Street Journal reports. When Walgreens agreed to buy its rival in October 2015 the sales price of $9 a share valued Rite Aid at $9.4B.

Executives at both firms hope selling off more stores will make the deal less troublesome to the Federal Trade Commission, which took issue with the merger since it would create a drugstore chain totaling over 10,000 U.S. stores. Earlier this month Walgreens indicated it has no backup plan should the merger fail. [WSJ]

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's National Newsletters
Related Stories

REPORT: Amazon Eyes Next Industrial Push With Plans To Expand Same-Day Deliveries

Fed Raises Benchmark Rate, Intensifying Borrowing Cost Blues

Stockdale Hires Fortress Exec To Launch Debt Business

Lone Star Seeks 58% Uplift In Under 3 Years With £175M UK Mall Sale

Inside The Nationwide Jockeying For Opportunity Zones 2.0

Furniture Outlet The Dump Is Getting Dumped In Atlanta

Simon Approaching End Of The Road With Struggling Suburban Boston Mall

GTIS Partners Rebrands As Brightshore Capital, Launches $250M Debt Platform

Data Center Spills 5,000 Gallons Of Fuel Into New Jersey River

Hines And Rialto Close Office Credit Fund At $1.1B

Chipotle Adding Hundreds Of New Locations Worldwide

'Beyond A Routine Wobble': 10-Year Treasury Clears 5% Ahead Of Key Fed Meeting